Literature DB >> 11457764

Myogenic satellite cells: physiology to molecular biology.

T J Hawke1, D J Garry.   

Abstract

Adult skeletal muscle has a remarkable ability to regenerate following myotrauma. Because adult myofibers are terminally differentiated, the regeneration of skeletal muscle is largely dependent on a small population of resident cells termed satellite cells. Although this population of cells was identified 40 years ago, little is known regarding the molecular phenotype or regulation of the satellite cell. The use of cell culture techniques and transgenic animal models has improved our understanding of this unique cell population; however, the capacity and potential of these cells remain ill-defined. This review will highlight the origin and unique markers of the satellite cell population, the regulation by growth factors, and the response to physiological and pathological stimuli. We conclude by highlighting the potential therapeutic uses of satellite cells and identifying future research goals for the study of satellite cell biology.

Mesh:

Year:  2001        PMID: 11457764     DOI: 10.1152/jappl.2001.91.2.534

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  434 in total

1.  GaAs 904-nm laser irradiation improves myofiber mass recovery during regeneration of skeletal muscle previously damaged by crotoxin.

Authors:  Lucila H Silva; Meiricris T Silva; Rita M Gutierrez; Talita C Conte; Cláudio A Toledo; Marcelo S Aoki; Richard E Liebano; Elen H Miyabara
Journal:  Lasers Med Sci       Date:  2011-12-06       Impact factor: 3.161

2.  Muscle satellite cells from GRMD dystrophic dogs are not phenotypically distinguishable from wild type satellite cells in ex vivo culture.

Authors:  Zachary Berg; Lucas R Beffa; Daniel P Cook; D D W Cornelison
Journal:  Neuromuscul Disord       Date:  2011-01-28       Impact factor: 4.296

3.  Origin of muscle satellite cells in the Xenopus embryo.

Authors:  Randall S Daughters; Ying Chen; Jonathan M W Slack
Journal:  Development       Date:  2011-01-26       Impact factor: 6.868

4.  CD133 marks a myogenically primitive subpopulation in rhabdomyosarcoma cell lines that are relatively chemoresistant but sensitive to mutant HSV.

Authors:  Joseph G Pressey; Marilyn C Haas; Christine S Pressey; Virginia M Kelly; Jacqueline N Parker; G Yancey Gillespie; Gregory K Friedman
Journal:  Pediatr Blood Cancer       Date:  2012-03-09       Impact factor: 3.167

5.  Expression of a mutant lamin A that causes Emery-Dreifuss muscular dystrophy inhibits in vitro differentiation of C2C12 myoblasts.

Authors:  Catherine Favreau; Dominique Higuet; Jean-Claude Courvalin; Brigitte Buendia
Journal:  Mol Cell Biol       Date:  2004-02       Impact factor: 4.272

6.  Number and spatial distribution of nuclei in the muscle fibres of normal mice studied in vivo.

Authors:  J C Bruusgaard; K Liestøl; M Ekmark; K Kollstad; K Gundersen
Journal:  J Physiol       Date:  2003-06-17       Impact factor: 5.182

7.  COX-2 inhibitor reduces skeletal muscle hypertrophy in mice.

Authors:  Margaret L Novak; William Billich; Sierra M Smith; Kunal B Sukhija; Thomas J McLoughlin; Troy A Hornberger; Timothy J Koh
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-01-28       Impact factor: 3.619

8.  ADAM12 and alpha9beta1 integrin are instrumental in human myogenic cell differentiation.

Authors:  Peggy Lafuste; Corinne Sonnet; Bénédicte Chazaud; Patrick A Dreyfus; Romain K Gherardi; Ulla M Wewer; François-Jérôme Authier
Journal:  Mol Biol Cell       Date:  2004-12-01       Impact factor: 4.138

9.  Large Polyglutamine Repeats Cause Muscle Degeneration in SCA17 Mice.

Authors:  Shanshan Huang; Su Yang; Jifeng Guo; Sen Yan; Marta A Gaertig; Shihua Li; Xiao-Jiang Li
Journal:  Cell Rep       Date:  2015-09-17       Impact factor: 9.423

10.  Laminin-111 restores regenerative capacity in a mouse model for alpha7 integrin congenital myopathy.

Authors:  Jachinta E Rooney; Praveen B Gurpur; Zipora Yablonka-Reuveni; Dean J Burkin
Journal:  Am J Pathol       Date:  2008-12-12       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.